Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1997 2
1999 2
2000 1
2001 1
2002 2
2003 3
2004 5
2005 2
2006 3
2007 3
2008 2
2009 1
2010 2
2011 2
2012 3
2013 2
2014 1
2015 1
2016 2
2017 1
2018 2
2020 3
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Ribonucleicacid interference or small molecule inhibition of Runx1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction.
Martin TP, MacDonald EA, Bradley A, Watson H, Saxena P, Rog-Zielinska EA, Raheem A, Fisher S, Elbassioni AAM, Almuzaini O, Booth C, Campbell M, Riddell A, Herzyk P, Blyth K, Nixon C, Zentilin L, Berry C, Braun T, Giacca M, McBride MW, Nicklin SA, Cameron ER, Loughrey CM. Martin TP, et al. Among authors: loughrey cm. Cardiovasc Res. 2023 Dec 19;119(16):2663-2671. doi: 10.1093/cvr/cvad107. Cardiovasc Res. 2023. PMID: 37433039 Free PMC article.
RUNX1: an emerging therapeutic target for cardiovascular disease.
Riddell A, McBride M, Braun T, Nicklin SA, Cameron E, Loughrey CM, Martin TP. Riddell A, et al. Among authors: loughrey cm. Cardiovasc Res. 2020 Jul 1;116(8):1410-1423. doi: 10.1093/cvr/cvaa034. Cardiovasc Res. 2020. PMID: 32154891 Free PMC article. Review.
Preclinical models of myocardial infarction: from mechanism to translation.
Martin TP, MacDonald EA, Elbassioni AAM, O'Toole D, Zaeri AAI, Nicklin SA, Gray GA, Loughrey CM. Martin TP, et al. Among authors: loughrey cm. Br J Pharmacol. 2022 Mar;179(5):770-791. doi: 10.1111/bph.15595. Epub 2021 Aug 11. Br J Pharmacol. 2022. PMID: 34131903 Free article. Review.
Sudden unexpected death in infancy (SUDI).
Loughrey CM, Preece MA, Green A. Loughrey CM, et al. J Clin Pathol. 2005 Jan;58(1):20-1. doi: 10.1136/jcp.2004.020677. J Clin Pathol. 2005. PMID: 15623476 Free PMC article. Review. No abstract available.
Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size.
He W, McCarroll CS, Nather K, Ford K, Mangion K, Riddell A, O'Toole D, Zaeri A, Corcoran D, Carrick D, Lee MMY, McEntegart M, Davie A, Good R, Lindsay MM, Eteiba H, Rocchiccioli P, Watkins S, Hood S, Shaukat A, McArthur L, Elliott EB, McClure J, Hawksby C, Martin T, Petrie MC, Oldroyd KG, Smith GL; Oxford Acute Myocardial Infarction (OxAMI) Study; Channon KM, Berry C, Nicklin SA, Loughrey CM. He W, et al. Among authors: loughrey cm. Cardiovasc Res. 2022 May 6;118(6):1535-1547. doi: 10.1093/cvr/cvab204. Cardiovasc Res. 2022. PMID: 34132807 Free PMC article.
Runx1 Deficiency Protects Against Adverse Cardiac Remodeling After Myocardial Infarction.
McCarroll CS, He W, Foote K, Bradley A, Mcglynn K, Vidler F, Nixon C, Nather K, Fattah C, Riddell A, Bowman P, Elliott EB, Bell M, Hawksby C, MacKenzie SM, Morrison LJ, Terry A, Blyth K, Smith GL, McBride MW, Kubin T, Braun T, Nicklin SA, Cameron ER, Loughrey CM. McCarroll CS, et al. Among authors: loughrey cm. Circulation. 2018 Jan 2;137(1):57-70. doi: 10.1161/CIRCULATIONAHA.117.028911. Epub 2017 Oct 13. Circulation. 2018. PMID: 29030345 Free PMC article.
48 results